$MRK News Health-care sector taking a broad beating as

New Post Public Reply Private Reply Replies (0) Message Board

Jan 4, 2015 at 10:22 AM

$MRK News

Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
FDA approves Bristol-Myers’s skin cancer treatment Opdivo 6:09 p.m. Dec. 22, 2014 - Ron Winslow
Nike slips after hours as orders fail to impress 6:38 p.m. Dec. 18, 2014 - MarketWatch
Merck acquires OncoEthix for up to $375 million 8:41 a.m. Dec. 18, 2014 - Angela Chen
From China to the U.S., a surreal week in business news 9:28 a.m. Dec. 12, 2014 - Marek Fuchs
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
Restoration Hardware shares jump on earnings beat 6:46 p.m. Dec. 10, 2014 - MarketWatch
Merck drug shrank tumors in some breast cancer patients in trial 8:57 a.m. Dec. 10, 2014 - Peter Loftus
Here are today’s biggest S&P 500 losers ... and five winners 12:51 p.m. Dec. 9, 2014 - Philip van Doorn
H&R Block shares fall on quarterly miss 6:41 p.m. Dec. 8, 2014 - Sue Chang
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Sara Sjolin
Russell 2000 rattles cage on major resistance 11:15 a.m. Dec. 8, 2014 - Michael Ashbaugh
Dow 18,000 beckons, but a bottom in oil prices does not 7:42 a.m. Dec. 8, 2014 - Shawn Langlois
Newscast: Oil prices plunge 7:38 a.m. Dec. 8, 2014 - MarketWatch
Merck to buy Cubist Pharmaceuticals for $8.4 billion 7:26 a.m. Dec. 8, 2014 - Peter Loftus
Merck to buy Cubist Pharmaceuticals in $9.5 billion deal 7:13 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co. to buy Cubist Pharma in total deal valued at $9.5 billion 7:05 a.m. Dec. 8, 2014 - Carla Mozee
Merck's per-share bid for Cubist's stock is 37% above Friday's closing price 7:03 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co.: Cubist Pharma purchase is a 35% premium to shareholders 7:03 a.m. Dec. 8, 2014 - Carla Mozee
Merck to pay $102 a share for Cubist 7:02 a.m. Dec. 8, 2014 - Tomi Kilgore

9 Hot Healthcare Dividend Dogs Dog 12% To 46% December Upsides 2:11 a.m. Today - Seeking Alpha
Today’s Top 5 Stock Picks: Innovative Global Values 11:44 a.m. Jan. 2, 2015 - Barrons.com
45 Blue-Chip Dividend Stocks That Increased Payouts in Q4 2014 8:32 a.m. Jan. 2, 2015 - InvestorPlace.com
3 Best American Funds for 2015 12:30 a.m. Jan. 2, 2015 - InvestorPlace.com
Despite Positive Phase 3 Results, Radius Health May Warrant A Short Sale 5:00 a.m. Dec. 31, 2014 - Seeking Alpha
Gilead Long-Term Prognosis Is Promising 2:10 p.m. Dec. 30, 2014 - Seeking Alpha
Esperion Therapeutics: ETC-1002 Is Appealing, But The Valuation Is Not 7:22 a.m. Dec. 30, 2014 - Seeking Alpha
DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially 7:05 a.m. Dec. 30, 2014 - Seeking Alpha
Health Care SPDR Consolidating Gains as J&J, Merck Show Negative Trends 6:10 a.m. Dec. 30, 2014 - TheStreet.com
Why Dogs Of The Dow Doesn't Work Anymore 4:46 a.m. Dec. 30, 2014 - Seeking Alpha
Tetraphase Hits 52-Week High on Positive Antibiotic Data - Analyst Blog 12:10 p.m. Dec. 29, 2014 - Zacks.com
NewLink and Merck Get a $30M Contract for Ebola Candidate - Analyst Blog 12:00 p.m. Dec. 29, 2014 - Zacks.com
5 Top Pharmaceutical Stock Picks for 2015 9:35 a.m. Dec. 29, 2014 - 247WallSt.com
Should You Buy the Dogs of the Dow in 2015? 6:20 a.m. Dec. 29, 2014 - InvestorPlace.com
The Real Source Of A Santa Claus Rally 8:35 p.m. Dec. 26, 2014 - Seeking Alpha
Viral Investing: Ebola Drug Makers' Varied Strategies 3:09 p.m. Dec. 26, 2014 - Investors Business Daily
4 Potential Blockbuster Drugs The FDA Just Approved 11:35 a.m. Dec. 26, 2014 - Investors Business Daily
Merck's Diabetes Pipeline Candidates Are Sure Bets; Only A Matter Of When 10:58 a.m. Dec. 26, 2014 - Seeking Alpha
Can You Retire In Your 50s? 2:38 a.m. Dec. 26, 2014 - Seeking Alpha
Bristol-Myers Oncology Drug Opdivo Receives FDA Approval - Analyst Blog 5:45 p.m. Dec. 23, 2014 - Zacks.com

EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:01 a.m. Dec. 29, 2014 - Marketwired
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 202 7:08 a.m. Dec. 23, 2014 - PR Newswire - PRF
Harris & Harris Group Notes Publicly Traded Portfolio Company Enumeral Biomedical's Collaboration With Merck 12:29 p.m. Dec. 22, 2014 - GlobeNewswire
NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award 8:01 a.m. Dec. 22, 2014 - GlobeNewswire
Alnylam Announces Planned Departure of Chief Business Officer, Laurence Reid, Ph.D. 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
Merck Begins Tender Offer to Acquire Cubist 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
Electrochromic Glass Market Will Reach $ 2.2 billion by 2020 says New NanoMarkets Report 11:14 a.m. Dec. 18, 2014 - PR Newswire - PRF
New Energy a Little More Insulated to Sharp Drop in Oil than Before 9:53 a.m. Dec. 18, 2014 - ACCESSWIRE
Enumeral and Merck Form Collaboration for Predicting Clinical Drug Response with Human-driven Immune Profiling Platform 8:02 a.m. Dec. 18, 2014 - BusinessWire - BZX
Merck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers 7:30 a.m. Dec. 18, 2014 - BusinessWire - BZX
Hemispherx's Ampligen(R) Provides Anti-Tumor Activity Analogous to Emerging Immune Checkpoint Inhibitors 8:31 a.m. Dec. 16, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company 7:07 p.m. Dec. 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Cubist Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information 5:07 p.m. Dec. 12, 2014 - BusinessWire - BZX
CBST SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc.in Connection With the Fairness of the Sale of the Companyto Merck & Co. 10:19 a.m. Dec. 12, 2014 - BusinessWire - BZX
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
CBST SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company to Merck & Co. 12:51 p.m. Dec. 10, 2014 - BusinessWire - BZX
Merck Announces Appointment of Dr. Julie Gerberding as Executive Vice President for Strategic Communications, Global Public Policy and Population Health 9:30 a.m. Dec. 10, 2014 - BusinessWire - BZX
International Breast Cancer Study Group, Breast International Group and Merck Announce Opening of International PANACEA Study of Patients with HER2+ Breast Cancer 8:45 a.m. Dec. 10, 2014 - BusinessWire - BZX
Data Investigating KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Advanced Triple-Negative Breast Cancer Presented at 2014 San Antonio Breast Cancer Symposium 8:30 a.m. Dec. 10, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elbphilharmonie Hamburg: 10th Anniversary Marks Milestone

Elbphilharmonie's Impact on Hamburg's Cultural Landscape Here we are, staring down the first decade of the Elbphilharmonie, and boy, if that isn't a testament to sticking your neck out for culture, I don't know what is. Opened back on January 11, 2017, this concert hall started as just another controversial project, folks wagging tongues about costs and ambition. But...

Grovenstein Earns Top Franchisee Honor from IFA

A Well-Earned Accolade in Franchising When you've got your finger on the pulse of the franchise business, it’s hard to ignore the likes of Rebecca Grovenstein snagging the IFA Franchisee of the Year award. Running a business ain't for the faint of heart, let alone steering multiple franchises to success. Grovenstein's operations of Lightbridge Academy in Apex and Holly...

Singlewire's Alert Badge Wins Vision Award in 2026

A Badge That Reshapes Communication Safety You might think a simple badge wouldn't earn much fanfare, but here we are — the InformaCast Wearable Alert Badge from Singlewire Software has snagged a prestigious spot at FacilitiesNet's 2026 Vision Awards. What makes this badge special? Well, it's not just a bauble to pin on your lapel; it's a deceptively simple yet powerful...

Telit Cinterion Secures U.S. Manufacturing with PA Facility

Telit Cinterion Takes a Bold Step in U.S. Manufacturing Here's a move you don't see every day: Telit Cinterion, one of the leading players in the IoT scene, is planting its flag firmly in the good ol' U.S. of A. They're ramping up to start churning out 4G and 5G IoT modules right on American soil by October 2026. This isn't just a small-scale ambition, folks. We're...

Vertiv's Bold $1.45B Buyout to Enhance AI Data Centers

Vertiv Snatches Up UtilityInnovation Group for $1.45 Billion Throw a stone into the tech sector, and it's bound to hit something about AI or data centers these days. Well, Vertiv Holdings Co. (NYSE: VRT) has made a splash by announcing a meaty $1.45 billion transaction to acquire UtilityInnovation Group (UIG). This move isn't just a bid to dust off the company's resume;...

Plan A Bets on AI in High-Stakes M&A Arena

Digging Deeper with AI in M&A Deals Picture this: you’re at the table with a fat corporate M&A deal, eyes darting as you decipher numbers and nods, when out swings Plan A Technologies with their new ace up their sleeve—a stealth AI assessment tool armed to sharpen their technical due diligence. Unmasking the Tech Jigsaw Las Vegas-based Plan A Technologies hasn't just...

Spencer Spirit Completes Hot Topic Acquisition

Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...

Soleno Therapeutics Faces Shareholder Legal Scrutiny

Legal Storm Brews for Soleno's Execs When you see Kuehn Law stepping into the ring, you know someone’s ruffling feathers. And this time, the target is Soleno Therapeutics (NASDAQ:SLNO), a name that might ring bells for tech folks dabbling in biotech. They’re under the spotlight because a federal securities lawsuit claims a questionable playbook was in the shuffle....

Flotek Faces Lawsuit: Investors Urged to Act Fast

Flotek's Current Storm: Gather Your Wits, Shareholders If you've staked your hard-earned cash into Flotek Industries, Inc. (FTK), it's high time to buckle up. Those court-blaring sirens aren’t a drill: we're talking class-action territory, people. The Law Offices of Howard G. Smith sound the alarm, calling on investors who’ve had their financial feathers singed to...

BlueSky Enters Nashville: In-Home Vet Care Begins

Nashville Welcomes A New Wave of Pet Care In a world where convenience is king, BlueSky At-Home Veterinary Care is stepping up to the plate—or should I say, doorstep—by rolling out its fresh take on veterinary services in Nashville. Kicking off on September 15, 2026, this isn't just any ol' run-of-the-mill clinic opening. We're talking about vets coming straight to...